Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance.

about

Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance.

Item

http://www.wikidata.org/entity/Q48199667

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Empagliflozin decreases remnan ...... ients with insulin resistance.

@en

Empagliflozin decreases remnan ...... ients with insulin resistance.

@nl

type

Item

label

Empagliflozin decreases remnan ...... ients with insulin resistance.

@en

Empagliflozin decreases remnan ...... ients with insulin resistance.

@nl

prefLabel

Empagliflozin decreases remnan ...... ients with insulin resistance.

@en

Empagliflozin decreases remnan ...... ients with insulin resistance.

@nl

P1476

Empagliflozin decreases remnan ...... ients with insulin resistance.

@en

P2093

Sachiko Hattori

http://www.w3.org/2001/XMLSchema#string

P2860

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials.

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.

Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus.

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease.

Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers.

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.

Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study.

P304

870-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDI.12781

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sachiko Hattori

P577

2017-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29193767

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

6031503

http://www.w3.org/2001/XMLSchema#string